CSBR vs KEYS · P/E 16, rev $56.9M vs P/E 57, rev $4.98B
Champions Oncology Inc (CSBR) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the CSBR and KEYS stock pages for the full models.
Not investment advice.